Difference between revisions of "Team:Tokyo Tech/Project-Constraction.html"
(Created page with "<!DOCTYPE html> <html > <head> <!-- Site made with Mobirise Website Builder v4.8.4, https://mobirise.com --> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" co...") |
|||
| (6 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<!DOCTYPE html> | <!DOCTYPE html> | ||
| + | {{Tokyo_Tech/mobirise/nav-bar}} | ||
| + | |||
<html > | <html > | ||
<head> | <head> | ||
| Line 10: | Line 12: | ||
<meta name="description" content="iGEM Tokyo Tech Project Constraction"> | <meta name="description" content="iGEM Tokyo Tech Project Constraction"> | ||
<title>Constraction</title> | <title>Constraction</title> | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
</head> | </head> | ||
<body> | <body> | ||
| − | |||
| − | + | <section class="engine"><a href="https://mobirise.info/t">amp templates</a></section><section class="mbr-section content5 cid-r5GT6OoMC7 mbr-parallax-background" id="content5-p"> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<div class="container"> | <div class="container"> | ||
| Line 73: | Line 30: | ||
<h2 class="align-center mbr-bold mbr-white pb-3 mbr-fonts-style display-1">Constraction</h2> | <h2 class="align-center mbr-bold mbr-white pb-3 mbr-fonts-style display-1">Constraction</h2> | ||
<h3 class="mbr-section-subtitle align-center mbr-light mbr-white pb-3 mbr-fonts-style display-5">For the pseudovirus production, we prepared structural gene, and non-structural gene with fluorescence protein gene.<div><br></div></h3> | <h3 class="mbr-section-subtitle align-center mbr-light mbr-white pb-3 mbr-fonts-style display-5">For the pseudovirus production, we prepared structural gene, and non-structural gene with fluorescence protein gene.<div><br></div></h3> | ||
| − | + | ||
| − | + | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 82: | Line 39: | ||
<section class="cid-r6Hr35Dfzm" id="image1-2s"> | <section class="cid-r6Hr35Dfzm" id="image1-2s"> | ||
| − | + | ||
<figure class="mbr-figure container"> | <figure class="mbr-figure container"> | ||
<div class="image-block" style="width: 66%;"> | <div class="image-block" style="width: 66%;"> | ||
| − | < | + | <img src="https://static.igem.org/mediawiki/2018/7/7c/T--Tokyo_Tech--const_parts.png |
| − | + | " width="1400" alt="Mobirise" title=""> | |
| + | |||
</div> | </div> | ||
</figure> | </figure> | ||
| Line 93: | Line 51: | ||
<section class="mbr-section article content1 cid-r6Hr49L28o" id="content1-2t"> | <section class="mbr-section article content1 cid-r6Hr49L28o" id="content1-2t"> | ||
| − | + | ||
| − | + | ||
<div class="container"> | <div class="container"> | ||
| Line 105: | Line 63: | ||
<section class="mbr-section content4 cid-r6HrDQLE2k" id="content4-2u"> | <section class="mbr-section content4 cid-r6HrDQLE2k" id="content4-2u"> | ||
| − | + | ||
<div class="container"> | <div class="container"> | ||
| Line 112: | Line 70: | ||
<h2 class="align-center pb-3 mbr-fonts-style display-2"><div><br></div><div>Results (Electrophoresis)</div><div><br></div></h2> | <h2 class="align-center pb-3 mbr-fonts-style display-2"><div><br></div><div>Results (Electrophoresis)</div><div><br></div></h2> | ||
<h3 class="mbr-section-subtitle align-center mbr-light mbr-fonts-style display-5">As shown in Figure, we successfully obtained each part, ranging from C and prM-E to FP-FMDV2a with non-structural region.<br><br><a href="http://parts.igem.org/File:TokyoTech_2018_EPresult.png">http://parts.igem.org/File:TokyoTech_2018_EPresult.png</a><div><br></div></h3> | <h3 class="mbr-section-subtitle align-center mbr-light mbr-fonts-style display-5">As shown in Figure, we successfully obtained each part, ranging from C and prM-E to FP-FMDV2a with non-structural region.<br><br><a href="http://parts.igem.org/File:TokyoTech_2018_EPresult.png">http://parts.igem.org/File:TokyoTech_2018_EPresult.png</a><div><br></div></h3> | ||
| − | + | ||
</div> | </div> | ||
</div> | </div> | ||
| Line 120: | Line 78: | ||
<section class="mbr-section info1 cid-r6HrVUDrTD" id="info1-2v"> | <section class="mbr-section info1 cid-r6HrVUDrTD" id="info1-2v"> | ||
| − | |||
| − | + | ||
| + | |||
<div class="container"> | <div class="container"> | ||
<div class="row justify-content-center content-row"> | <div class="row justify-content-center content-row"> | ||
<div class="media-container-column title col-12 col-lg-7 col-md-6"> | <div class="media-container-column title col-12 col-lg-7 col-md-6"> | ||
| − | + | ||
<h2 class="align-left mbr-bold mbr-fonts-style display-2">Protocol</h2> | <h2 class="align-left mbr-bold mbr-fonts-style display-2">Protocol</h2> | ||
</div> | </div> | ||
| Line 137: | Line 95: | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
</body> | </body> | ||
</html> | </html> | ||
| + | {{Tokyo_Tech/mobirise/footer}} | ||
| + | {{Tokyo_Tech/mobirise/script}} | ||
Latest revision as of 07:11, 17 October 2018
<!DOCTYPE html>
Constraction
For the pseudovirus production, we prepared structural gene, and non-structural gene with fluorescence protein gene.
About structural gene, capsid (C), membrane (prM) and envelope (E) are necessary for the formation of viral structure. We prepared pCAG-C and pCAG-prM-E for Serotype I to IV. On the other hand, about non-structural gene with fluorescence protein gene, we prepared EGFP-FMDV2a, DsRed-Express-FMDV2a, ZsYellow-FMDV2a and AmCyan-FMDV2a, and inserted each of them to non-structural genes of dengue virus.
Since these plasmids are introduced into mammalian cells, the promoter and backbone should be optimized for eukaryotic cells. Our team uses pCAG vector which includes CAG promoter to induce high expression of interesting genes in mammalian cells, and pCMV for non-structural region.
